(Fighting against New Coronary Pneumonia) U.S. revokes emergency use authorizations for hydroxychloroquine and chloroquine
China News Agency, Houston, June 15th The US Food and Drug Administration (FDA) revoked an emergency use authorization for hydroxychloroquine and chloroquine on the 15th, and said the agency's latest clinical trials show that these drugs are The patient is invalid.
"Wall Street Journal" news, FDA chief scientist Dennis Hinton wrote in a letter that day, we think that "these two drugs may be effective in treating patients with new crowns" is no longer reasonable.
Patricia Cavazzoni, acting director of the FDA's Drug Evaluation Center, said that although some clinical trials are continuing to evaluate the potential benefits of these drugs in treating or preventing new coronavirus infections, FDA researchers have conducted After a rigorous evaluation, it is believed that this emergency use authorization no longer applies.
According to the US technology website "The Verge", on March 28, the FDA issued an emergency authorization to allow hydroxychloroquine and chloroquine to be used to treat patients with new crowns. The US Department of Health (HHS) also stated in a statement that pharmaceutical companies Sandoz and Bayer plan to donate more than 30 million doses of hydroxychloroquine and chloroquine products to the US National Strategic Reserve (SNS), which will be distributed to States across the United States.
According to the FDA, the agency’s latest research results show that the use of hydroxychloroquine or chloroquine in the treatment of patients with new crowns, whether or not combined with macrolide antibiotics (such as azithromycin), not only has no obvious effect, but also may increase the heart-related complications The risk of illness may even increase the risk of death.
The FDA said that hydroxychloroquine and chloroquine are drugs approved by the agency for the treatment of diseases such as malaria and lupus, and these drugs are still allowed to be marketed.
According to media reports, since the outbreak of the New Crown epidemic in the United States, President Trump said that hydroxychloroquine and chloroquine help prevent and treat infections of the new crown virus, and wrote on social media Twitter that hydroxychloroquine and the antibiotic azithromycin The combination has the opportunity to become "one of the biggest disruptive achievements in the history of medicine." In May, Trump also revealed that he was taking hydroxychloroquine to prevent infection with the new coronavirus.
Regarding the FDA’s withdrawal of the emergency use authorization, on June 15, Trump stated at the White House that he did not know about this decision. Trump said, "It certainly won't hurt me." (Finish)